OFIX
Income statement / Annual
Last year (2024), Orthofix Medical Inc.'s total revenue was $799.49 M,
an increase of 7.08% from the previous year.
In 2024, Orthofix Medical Inc.'s net income was -$123.88 M.
See Orthofix Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$799.49 M |
$746.64 M |
$460.71 M |
$464.48 M |
$406.56 M |
$459.96 M |
$453.04 M |
$433.82 M |
$409.79 M |
$396.49 M |
| Cost of Revenue |
$253.61 M
|
$260.37 M
|
$123.54 M
|
$114.91 M
|
$101.89 M
|
$100.61 M
|
$96.63 M
|
$93.04 M
|
$87.85 M
|
$86.53 M
|
| Gross Profit |
$545.89 M
|
$486.27 M
|
$337.17 M
|
$349.57 M
|
$304.67 M
|
$359.35 M
|
$356.41 M
|
$340.79 M
|
$321.94 M
|
$309.96 M
|
| Gross Profit Ratio |
0.68
|
0.65
|
0.73
|
0.75
|
0.75
|
0.78
|
0.79
|
0.79
|
0.79
|
0.78
|
| Research and Development Expenses |
$73.64 M
|
$80.23 M
|
$49.07 M
|
$49.62 M
|
$39.06 M
|
$34.64 M
|
$33.22 M
|
$29.70 M
|
$28.80 M
|
$26.39 M
|
| General & Administrative Expenses |
$0.00
|
$144.66 M
|
$79.97 M
|
$69.35 M
|
$67.95 M
|
$85.61 M
|
$84.51 M
|
$74.39 M
|
$74.40 M
|
$87.16 M
|
| Selling & Marketing Expenses |
$0.00
|
$385.74 M
|
$228.81 M
|
$221.32 M
|
$204.43 M
|
$223.68 M
|
$205.53 M
|
$198.37 M
|
$181.29 M
|
$178.08 M
|
| Selling, General & Administrative Expenses |
$532.53 M
|
$530.40 M
|
$308.78 M
|
$290.67 M
|
$272.38 M
|
$309.28 M
|
$290.03 M
|
$272.76 M
|
$255.69 M
|
$265.24 M
|
| Other Expenses |
$24.34 M
|
$14.76 M
|
-$3.15 M
|
-$3.34 M
|
$8.38 M
|
-$8.14 M
|
-$6.38 M
|
-$4.00 M
|
-$17.18 M
|
-$259,000.00
|
| Operating Expenses |
$630.50 M
|
$625.38 M
|
$357.84 M
|
$340.29 M
|
$311.44 M
|
$343.92 M
|
$323.25 M
|
$302.46 M
|
$284.49 M
|
$291.63 M
|
| Cost And Expenses |
$884.11 M
|
$885.75 M
|
$481.39 M
|
$455.21 M
|
$413.33 M
|
$444.53 M
|
$419.88 M
|
$395.50 M
|
$372.35 M
|
$378.15 M
|
| Interest Income |
$0.00
|
$0.00
|
$1.29 M
|
$1.84 M
|
$2.48 M
|
$122,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$29.63 M
|
$8.63 M
|
$1.29 M
|
$1.84 M
|
$2.48 M
|
$122,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$76.00 M
|
$60.60 M
|
$29.02 M
|
$29.60 M
|
$30.55 M
|
$24.70 M
|
$18.66 M
|
$20.12 M
|
$20.84 M
|
$20.92 M
|
| EBITDA |
-$18.24 M |
-$86.99 M |
$12.60 M |
$17.94 M |
$32.66 M |
-$2.23 M |
$41.54 M |
$60.94 M |
$39.87 M |
$29.92 M |
| EBITDA Ratio |
-0.02
|
-0.12
|
-0.05
|
0.06
|
0.09
|
0.11
|
0.08
|
0.08
|
0.1
|
0.07
|
| Operating Income Ratio |
-0.11
|
-0.19
|
-0.04
|
-0.01
|
0
|
0.05
|
0.07
|
0.09
|
0.05
|
0.02
|
| Total Other Income/Expenses Net |
-$39.26 M
|
-$9.57 M
|
-$4.44 M
|
-$5.18 M
|
-$366,500.00
|
-$8.27 M
|
-$7.21 M
|
-$4.42 M
|
-$2.04 M
|
-$748,000.00
|
| Income Before Tax |
-$123.88 M
|
-$148.68 M
|
-$17.71 M
|
-$13.50 M
|
-$368,000.00
|
-$27.05 M
|
$22.89 M
|
$36.39 M
|
$19.02 M
|
$8.51 M
|
| Income Before Tax Ratio |
-0.15
|
-0.2
|
-0.04
|
-0.03
|
-0
|
-0.06
|
0.05
|
0.08
|
0.05
|
0.02
|
| Income Tax Expense |
$2.12 M
|
$2.72 M
|
$2.04 M
|
$24.88 M
|
-$2.89 M
|
$1.41 M
|
$9.07 M
|
$29.10 M
|
$15.53 M
|
$10.85 M
|
| Net Income |
-$123.88 M
|
-$151.40 M
|
-$19.75 M
|
-$38.38 M
|
$2.52 M
|
-$28.46 M
|
$13.81 M
|
$6.22 M
|
$3.06 M
|
-$2.81 M
|
| Net Income Ratio |
-0.15
|
-0.2
|
-0.04
|
-0.08
|
0.01
|
-0.06
|
0.03
|
0.01
|
0.01
|
-0.01
|
| EPS |
-3.25 |
-4.12 |
-0.98 |
-1.95 |
0.13 |
-1.51 |
0.75 |
0.34 |
0.17 |
-0.15 |
| EPS Diluted |
-3.25 |
-4.12 |
-0.98 |
-1.95 |
0.13 |
-1.51 |
0.73 |
0.34 |
0.17 |
-0.15 |
| Weighted Average Shares Out |
$38.13 M
|
$36.73 M
|
$20.05 M
|
$19.69 M
|
$19.27 M
|
$18.90 M
|
$18.49 M
|
$18.12 M
|
$18.14 M
|
$18.80 M
|
| Weighted Average Shares Out Diluted |
$38.13 M
|
$36.73 M
|
$20.05 M
|
$19.69 M
|
$19.39 M
|
$18.90 M
|
$18.91 M
|
$18.50 M
|
$18.46 M
|
$18.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
